The Cooper Companies, Inc. $COO Holdings Decreased by Legal & General Group Plc

Legal & General Group Plc decreased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 26.6% in the fourth quarter, Holdings Channel.com reports. The firm owned 937,729 shares of the medical device company’s stock after selling 339,809 shares during the period. Legal & General Group Plc’s holdings in Cooper Companies were worth $76,856,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. New York Life Investment Management LLC boosted its stake in shares of Cooper Companies by 0.6% during the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock worth $2,241,000 after acquiring an additional 158 shares in the last quarter. Allworth Financial LP raised its holdings in Cooper Companies by 14.1% in the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after acquiring an additional 167 shares in the last quarter. Mesirow Financial Investment Management Inc. grew its stake in shares of Cooper Companies by 1.3% in the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock valued at $961,000 after purchasing an additional 175 shares during the period. Blue Trust Inc. grew its stake in shares of Cooper Companies by 13.9% in the 4th quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock valued at $124,000 after purchasing an additional 185 shares during the period. Finally, Norden Group LLC grew its stake in shares of Cooper Companies by 3.2% in the 4th quarter. Norden Group LLC now owns 6,634 shares of the medical device company’s stock valued at $544,000 after purchasing an additional 205 shares during the period. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Trading Up 0.3%

Cooper Companies stock opened at $61.21 on Friday. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34. The stock has a market capitalization of $11.94 billion, a P/E ratio of 30.30, a PEG ratio of 1.57 and a beta of 0.89. The stock has a 50-day simple moving average of $65.96 and a 200 day simple moving average of $74.87.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. During the same quarter last year, the company posted $0.92 earnings per share. Cooper Companies’s quarterly revenue was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Analysts expect that The Cooper Companies, Inc. will post 4.62 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. Citigroup restated a “neutral” rating and set a $69.00 price target (down from $80.00) on shares of Cooper Companies in a research report on Thursday. William Blair raised Cooper Companies to a “strong-buy” rating in a research note on Friday, January 30th. Barclays increased their price target on Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, March 6th. Rothschild & Co Redburn downgraded Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price objective on the stock. in a research note on Wednesday, March 4th. Finally, Needham & Company LLC raised their price objective on Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a research note on Friday, March 6th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $88.64.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.